The pharmaceutical supply chain: Are we ready for change?
Latest EU drug approvals span range of health issues
Lonza signs new long-term agreement with Alexion
Alexion Pharmaceuticals announces €450m expansion in Dublin
Alexion to acquire Synageva to develop rare disease therapies
Orphan drugs market offers many opportunities for drug development, says new study
A lucrative niche in orphan diseases?
Alexion to acquire Enobia Pharma for US$610m
Almac responds to request for rapid packaging and distribution
Alexion acquires Taligen Therapeutics